Prospective, Open-labelled, Phase II Study, of the Administration of Desmopressin in Patients With Colorectal Cancer, With or Without Metastasis, With Rectal Bleeding, Before Treatment With Surgery and/or Chemotherapy and/or Radiotherapy.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Desmopressin (Primary)
- Indications Colorectal cancer; Rectal bleeding
- Focus Adverse reactions
- Sponsors Elea
- 23 Aug 2017 Status changed from recruiting to completed.
- 05 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
- 05 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.